Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study

被引:7
|
作者
Herman, Bumi [1 ,2 ]
Wong, Martin Chi-Sang [3 ,4 ,5 ]
Viwattanakulvanid, Pramon [1 ]
机构
[1] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand
[2] Hasanuddin Univ, Fac Med, Res Dev & Publicat, Makassar, Indonesia
[3] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care JCSPHPC, Shatin, Hong Kong, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
[5] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China
来源
PLOS ONE | 2022年 / 17卷 / 07期
关键词
D O I
10.1371/journal.pone.0271385
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Post-COVID symptoms are the new concern in the COVID-19 pandemic, where recovered patients experience residual symptoms affecting their quality of life. Therefore, it is imperative to evaluate the role of complete vaccination, prescribed medication, and micronutrients during COVID episodes in the occurrence of post-COVID symptoms. Method A longitudinal evaluation of Indonesia's recovered COVID-19 patients was performed using the data collected from July 2021 and extracted in mid-February 2022. All participants were confirmed with a Real-Time Polymerase Chain Reaction test (PCR) and/or antigen test. This study collected demography and comorbidities information, symptoms and treatment of COVID-19, and collection of self-reported post-COVID symptoms every 30 days within 90 days after diagnosis/onset. Exposures of interest include vaccination status, Favipiravir administration, Vitamin C, Vitamin D, and Zinc. A Generalized Estimating Equation (GEE) was used to evaluate the longitudinal effect of exposures, presented with adjusted odds ratios and its 95% confidence interval. Results A total of 923 participants (18.2% fully-vaccinated) were involved in the study, with 79.7% being non-hospitalized. Only 25.7% did not develop any residual symptoms within 90 days. Fatigue was the most reported post-COVID symptom in each measurement time (39.5%, 16.3%, and 7.3%). Full-vaccination was effective against chronic cough (aOR 0.527, 95% CI 0.286-0.971), chronic headache (aOR 0.317, 95% CI 0.163-0.616), and chronic arthritis (aOR 0.285, 95% CI 0.116-0.703). The combination of micronutrient supplementations and Favipiravir gave no significant effect on all post-COVID symptoms. However, early initiation of Favipiravir and delaying vitamin D administration were associated with arthritis. Conclusion Full vaccination of COVID-19 prevents the disease and the development of residual symptoms when infected with SARS-COV-2. Hence, it is crucial to reconsider the prescription of micronutrient supplementation or adjust the dose of Favipiravir in the current guideline.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] The potential impact of post-COVID symptoms in the healthcare sector
    Tempany, M.
    Leonard, A.
    Prior, A. R.
    Boran, G.
    Reilly, P.
    Murray, C.
    O'Brien, M.
    Maguire, G.
    Ennis, D.
    Rakovac, A.
    Reid, A.
    OCCUPATIONAL MEDICINE-OXFORD, 2021, 71 (6-7): : 284 - 289
  • [32] PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study
    Ganesh, Ravindra
    Ghosh, Aditya K.
    Nyman, Mark A.
    Croghan, Ivana T.
    Grach, Stephanie L.
    Anstine, Christopher, V
    Salonen, Bradley R.
    Hurt, Ryan T.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2021, 12
  • [33] Tracking Health Beyond Recovery: A Study on Identifying Post-COVID Syndrome Symptoms
    Walvekar, Shreyas S.
    Mohite, Vaishali R.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2023, 28 (02) : 170 - 174
  • [34] Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis
    Tan, A.
    Stepien, K. M.
    Narayana, S. T. K.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (08) : 596 - 597
  • [35] COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    Thiruchelvam, Kaeshaelya
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 274 - 275
  • [36] Therapeutic approach to dysphagia in post-COVID patients in a rehabilitation unit, a descriptive longitudinal study
    Guillen-sola, Anna
    Ramirez, Cindry
    Nieto, Sonia
    Duarte, Esther
    Tejero, Marta
    Grillo, Christian
    Bel, Helena
    Boza, Roser
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2024, 60 (02) : 373 - 381
  • [37] Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months
    Eva Maria Martin
    Annie Srowig
    Isabelle Utech
    Simon Schrenk
    Fabian Kattlun
    Monique Radscheidt
    Stefan Brodoehl
    Peter Bublak
    Matthias Schwab
    Christian Geis
    Bianca Besteher
    Philipp A. Reuken
    Andreas Stallmach
    Kathrin Finke
    Journal of Neurology, 2024, 271 : 46 - 58
  • [38] Psychological Factors Predict Higher Odds and Impairment of Post-COVID Symptoms: A Prospective Study
    Milde, Christopher
    Glombiewski, Julia A.
    Wilhelm, Marcel
    Schemer, Lea
    PSYCHOSOMATIC MEDICINE, 2023, 85 (06): : 479 - 487
  • [39] Evaluating post-COVID care: a retrospective cohort study into long-term symptoms
    Yeo, Edward
    Visser, Edith
    Kuijvenhoven, Jolanda C.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [40] Lipid peroxidation in the development of some symptoms of post-COVID syndrome
    Grigorieva, A. A.
    Rumyantsev, E. K.
    Nikolaev, V. M.
    Olesova, L. D.
    Romanova, A. N.
    YAKUT MEDICAL JOURNAL, 2022, (01): : 83 - 86